Figure 1From: Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib Photograph of the patient while on sorafenib treatment showing hypopigmentation of face, hair loss over scalp, eye brows and moustache. Back to article page